Listing 1 - 2 of 2 |
Sort by
|
Choose an application
RICIN --- RECEPTORS, HISTAMINE --- MAMMALIAN CENTRAL NERVOUS SYSTEM --- MOLYBDENUM HYDROXYLASES --- PLATINUM --- CANNABINOID DRUGS --- ANTITUMOUR AGENTS --- HYPOGLYCAEMIC AGENTS --- INSULIN --- CALCIUM CHANNEL BLOCKERS --- ALDOSE REDUCTASE INHIBITORS --- ANTITUMOUR AGENTS --- RELEASE --- PHARMACOLOGY --- RICIN --- RECEPTORS, HISTAMINE --- MAMMALIAN CENTRAL NERVOUS SYSTEM --- MOLYBDENUM HYDROXYLASES --- PLATINUM --- CANNABINOID DRUGS --- ANTITUMOUR AGENTS --- HYPOGLYCAEMIC AGENTS --- INSULIN --- CALCIUM CHANNEL BLOCKERS --- ALDOSE REDUCTASE INHIBITORS --- ANTITUMOUR AGENTS --- RELEASE --- PHARMACOLOGY
Choose an application
HYPOGLYCAEMIC AGENTS --- LEUKOCYTE ELASTASE (INHIBITORS OF HUMAN...) --- AZIDO GROUP --- GASTRIC H+/K+ -ATPase INHIBITORS --- ANTIBIOTICS, MACROLIDE --- BETA-LACTAMASE --- TARGET FOR DRUG DESIGN --- DRUG DESIGN --- SILVER --- ENDOTHELINS --- POTASSIUM CHANNEL ACTIVATORS --- STRUCTURE-ACTIVITY RELATIONSHIPS --- TARGET FOR DRUG DESIGN --- INHIBITION OF THE PHARMACOLOGICAL EFFECTS --- HYPOGLYCAEMIC AGENTS --- LEUKOCYTE ELASTASE (INHIBITORS OF HUMAN...) --- AZIDO GROUP --- GASTRIC H+/K+ -ATPase INHIBITORS --- ANTIBIOTICS, MACROLIDE --- BETA-LACTAMASE --- TARGET FOR DRUG DESIGN --- DRUG DESIGN --- SILVER --- ENDOTHELINS --- POTASSIUM CHANNEL ACTIVATORS --- STRUCTURE-ACTIVITY RELATIONSHIPS --- TARGET FOR DRUG DESIGN --- INHIBITION OF THE PHARMACOLOGICAL EFFECTS
Listing 1 - 2 of 2 |
Sort by
|